Issue |
J Extra Corpor Technol
Volume 55, Number 4, December 2023
|
|
---|---|---|
Page(s) | 206 - 208 | |
DOI | https://doi.org/10.1051/ject/2023037 | |
Published online | 15 December 2023 |
Case Report
Central ECMO cannulation for severe dihydropyridine calcium channel blocker overdose
1
Division of Pediatric Cardiology Section of Cardiac Critical Care. University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
2
Department of Cardiovascular Perfusion Children’s of Alabama, Birmingham, AL, USA
3
ECMO Clinical Coordinator Children’s of Alabama, Birmingham, AL, USA
4
Department of Pediatric Emergency Medicine. University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
5
Department of Pediatric Critical Care. University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
* Corresponding author: jcardenasfimbres@yahoo.com
Received:
14
August
2023
Accepted:
5
October
2023
Calcium channel blocker (CCB) toxicity carries a high mortality and is the sixth most fatal drug class reported to US poison centers. Amlodipine overdose is characterized by a life-threatening arterial vasodilation that compromises organ perfusion. The management of CCB intoxication is focused on maintaining adequate organ perfusion. In cases refractory to medical therapies, hemodynamic support with extracorporeal membrane oxygenation (ECMO) is warranted necessitating higher flows than usual to compensate for the vasodilation and requiring central cannulation. We present a case of a 12-year-old with severe dihydropyridine CCB ingestion, refractory to medical management and successfully treated with central ECMO cannulation. The patient was discharged home with no significant disability. Central ECMO cannulation may be helpful to facilitate adequate flows in vasodilatory shock such as CCB overdose.
Key words: ECMO (extracorporeal membrane oxygenation) / Shock / Peripheral vascular disease / Pediatric / Pharmacology / cardiovascular
© The Author(s), published by EDP Sciences, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.